Abstract
In this second part of the Journal scan of this issue, we provide a brief overview of the late-breaking trials presented at the American College of Cardiology (ACC) Conference held in Atlanta, Georgia, from April 6 to 8, 2024, and their relevance to our daily clinical practice. The trials are categorized under the following headings: F. Lipidology (VICTORION INITIATE, SHASTA2, Liberate HR, Bridge-TIMI 73A, AEGIS II,) G. Artificial Intelligence (TACTic, Be Active, Tele ACS) H. Others (Deposition, Crescent, TACT2)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
